By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…
By: Mohamed Dungersi - On February 28, the U.S. Food and Drug Administration (FDA) approved important safety label changes for…